Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca abandons diabetes drug over safety concerns

May 5, 2006
Research and Development AstraZeneca, PPAR agonist

 AstraZeneca is to abandon its late-stage diabetes drug Galida after new results raised doubts about its safety.Galida is a PPAR …

News

Frontline NHS staff enlisted in fight against flab

May 5, 2006

The nation's increasing weight is to become top priority for frontline NHS staff in an effort to halt the rise …

News

AstraZeneca to co-market nanotechnology cancer drug

May 4, 2006
Sales and Marketing

Groundbreaking nanotechnology is behind a new drug, which AstraZeneca and co-marketers Abraxis BioScience believe could be a major advance in …

News

Project management: from apprentice to master

May 3, 2006
Research and Development, Sales and Marketing

When the three 'Apprentices' enter Mr. Sugars boardroom to explain why they made such a hash of their latest project, …

Feature

Is pharma fit for the future?

May 3, 2006
Sales and Marketing

It's getting personal. While the pharma industry continues to debate the end of the blockbuster model, hardly a single clinician, …

Feature

Positive results halt trial of new Herceptin rival

May 3, 2006
Research and Development

Better than expected results for a new drug for advanced breast cancer have led to trials being halted, in order …

News

Herceptin and the rise of patient power

May 3, 2006
Sales and Marketing

The controversy surrounding Herceptin and its use in patients with early stage breast cancer has become a graphic illustration of …

Feature

Brands:looking at the bigger picture

May 3, 2006
Sales and Marketing

While the prospect of a single-product company might seem attractive – no in-fighting over resource allocation, no conflicts of interest, …

Feature

‘Dawn of a new era’ as nurses and pharmacists take on full prescribing

May 3, 2006

Trained nurses and pharmacists in England now have the power to prescribe virtually any medicine, which could end the need …

News

Herceptin set for approval in early breast cancer

April 28, 2006
Sales and Marketing

Herceptin, the breast cancer drug at the centre of a long-running controversy could soon be available to thousands more women …

News

Helping doctors hit moving targets

April 26, 2006

Introduced in April 2004, the new General Medical Services contract (nGMS) was hailed as a revolutionary new way of paying …

Feature

Ex-Pfizer Stafford launches patient communication consultancy

April 26, 2006
Medical Communications patients

The needs of patients are being forgotten or over-looked by pharmaceutical companies, according to a newly launched consultancy called Patient …

News

Make small changes to ‘add years to your life’ urges government

April 26, 2006

Everyday, simple choices could be the key to a healthier lifestyle according to new government-backed research published by Cambridge University. …

News

Osteoporosis drug Evista can prevent breast cancer

April 26, 2006
Sales and Marketing

A new study of Lilly's Evista suggests it could help prevent postmenopausal women developing breast cancer.A major new study of …

News

Biotech buy helps Pfizer expand neuroscience research

April 26, 2006
Research and Development, Sales and Marketing Pfizer

Pfizer is to buy Californian Rinat Neuroscience, a biotech company which specialises in developing therapeutic proteins to treat central nervous …

News

Companies share secrets to reduce unforeseen phase I problems

April 26, 2006
Research and Development

Eight of the industry's leading companies have begun work on a unique new project to help overcome one of the …

News

UK pharma industry unites to take the Code to customers

April 26, 2006
Research and Development

Companies from across the UK pharma industry have come together in an unprecedented campaign to promote awareness of its code …

News

MPs set to probe health service finances as ‘crisis’ continues

April 26, 2006

MPs look set to launch an inquiry into the continuing problems in the NHS, as job cuts and fears of …

News

AstraZeneca celebrates success of FMCG marketer recruitment

April 26, 2006
Sales and Marketing

Targeted campaign pays off as the number of candidates joining the company from outside the pharma industry increases by five-fold …

News

Pfizer vows to fight ‘perverse and short-sighted decision’ on Exubera

April 24, 2006
Research and Development

Exubera, the world's first inhaled insulin, has failed to gain NICE approval after manufacturer Pfizer couldnt convince the Institute of …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026